Arkolith/Insider Trading/RVMD/Form 4

Horn Margaret A

Chief Operating OfficerRevolution Medicines, Inc. (RVMD) · full profile →Form 4 · filed Jun 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$15.0M
Net Open-Market Flow
-$15.0M
Transactions
13
8 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2026Option exercise(M)573$40.74$23K155K
Jun 17, 2026Option exercise(M)3K$29.80$98K159K
Jun 17, 2026Option exercise(M)26K$26.50$682K184K
Jun 17, 2026Sell(S)30K$160.12$4.7M155K
Jun 15, 2026Option exercise(M)16K$40.74$633K174K
Jun 15, 2026Option exercise(M)45K$29.80$1.3M219K
Jun 15, 2026Sell(S)60K$160.17$9.7M158K
Jun 16, 2025Sell(S)4K$156.12$558K155K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 17, 2026Option exercise(M)573—$075K
Jun 17, 2026Option exercise(M)3K—$072K
Jun 17, 2026Option exercise(M)26K—$0114K
Jun 15, 2026Option exercise(M)16K—$076K
Jun 15, 2026Option exercise(M)45K—$075K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000230) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML